Phase II study of oral etoposide maintenance for patients with extensive stage small cell lung cancer who have responded to the induction on an EP regimen
Author:
Affiliation:
1. Department Of Thoracic Oncology; West China Hospital; Sichuan University; Chengdu; Sichuan; China
2. West China Medical Center of Sichuan University; Chengdu; Sichuan; China
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12019/fullpdf
Reference27 articles.
1. Management of small-cell lung cancer;Thatcher;Ann Oncol,2005
2. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects;Demedts;Eur Respir J,2010
3. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer;Slevin;J Clin Oncol,1989
4. A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer;Murphy;Cancer,1992
5. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study;Wolff;J Clin Oncol,1995
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial;Investigational New Drugs;2023-10-14
2. In vitro studies of H520 cell cycle and apoptosis by anlotinib combined with radiotherapy;Thoracic Cancer;2021-01-12
3. The benefits of etoposide capsules as maintenance therapy for patients with extensive-stage small cell lung cancer: a prospective two-stage, two-center study;Journal of Thoracic Disease;2021-01
4. Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience;Journal of Oncology;2019-03-20
5. Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: A population-based propensity-score matched analysis;Thoracic Cancer;2014-10-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3